CTLA‑4 interferes with the HBV‑specific T cell immune response (Review)
- Authors:
- Hui Cao
- Ruiwen Zhang
- Wei Zhang
-
Affiliations: Department of Liver Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200030, P.R. China, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, TX 79106, USA - Published online on: May 17, 2018 https://doi.org/10.3892/ijmm.2018.3688
- Pages: 703-712
-
Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, et al: The global burden of viral hepatitis from 1990 to 2013: Findings from the global burden of disease study 2013. Lancet. 388:1081–1088. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lu FM, Li T, Liu S and Zhuang H: Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat. 17(Suppl 1): S4–S9. 2010. View Article : Google Scholar | |
|
Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D and Liu M: Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: A population-based, cross-sectional study. Lancet Infect Dis. 16:80–86. 2016. View Article : Google Scholar | |
|
Blendis L, Lurie Y and Oren R: Occult HBV infection-both hidden and mysterious. Gastroenterology. 125:1903–1905. 2003. View Article : Google Scholar | |
|
Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, et al: Hepatitis B virus - specific and global T-cell dysfunction in chronic hepatitis B. Gastroenterology. 150:684–695.e5. 2016. View Article : Google Scholar | |
|
Ye B, Liu X, Li X, Kong H, Tian L and Chen Y: T-cell exhaustion in chronic hepatitis B infection: Current knowledge and clinical significance. Cell Death Dis. 6:e16942015. View Article : Google Scholar : PubMed/NCBI | |
|
Ling V, Wu PW, Finnerty HF, Sharpe AH, Gray GS and Collins M: Complete sequence determination of the mouse and human CTLA4 gene loci: Cross-species DNA sequence similarity beyond exon borders. Genomics. 60:341–355. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lindsten T, Lee KP, Harris ES, Petryniak B, Craighead N, Reynolds PJ, Lombard DB, Freeman GJ, Nadler LM, Gray GS, et al: Characterization of CTLA-4 structure and expression on human T cells. J Immunol. 151:3489–3499. 1993.PubMed/NCBI | |
|
Adams AB, Ford ML and Larsen CP: Costimulation blockade in autoimmunity and transplantation: The CD 28 pathway. J Immunol. 197:2045–2050. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG and Golstein P: A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328:267–270. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Tang ST, Tang HQ, Zhang Q, Wang CJ, Wang YM and Peng WJ: Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: A meta-analysis. Gene. 508:165–187. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Wang B, Pan F, Zhang R, Xiao L, Guo H, Ma S and Zhou C: Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: Data from a multicenter study. J Gastroenterol Hepatol. 28:1397–1402. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Du L, Yang J and Huang J, Ma Y, Wang H, Xiong T, Xiang Z, Zhang Y and Huang J: The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population. BMC Med Genet. 14:462013. View Article : Google Scholar : PubMed/NCBI | |
|
Huang R, Hao Y, Fan Y, Yang C, Wu K, Cao S and Wu C: Association between cytotoxic T-lymphocyte-associated antigen 4+49A/G polymorphism and persistent hepatitis B virus infection in the Asian population: Evidence from the current studies. Genet Test Mol Biomarkers. 17:601–606. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Isogawa M, Furuichi Y and Chisari FV: Oscillating CD8+ T cell effector functions after antigen recognition in the liver. Immunity. 23:53–63. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Benechet AP and Iannacone M: Determinants of hepatic effector CD8+ T cell dynamics. J Hepatol. 66:228–233. 2017. View Article : Google Scholar | |
|
Bengsch B, Martin B and Thimme R: Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol. 61:1212–1219. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ and Ahmed R: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682–687. 2006. View Article : Google Scholar | |
|
Legat A, Speiser DE, Pircher H, Zehn D and Fuertes Marraco SA: Inhibitory receptor expression depends more dominantly on differentiation and activation than 'Exhaustion' of human CD8 T cells. Front Immunol. 4:4552013. View Article : Google Scholar | |
|
Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, Gostick E, Price DA, Freeman GJ, Wherry EJ and Chang KM: Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 5. pp. e10003132009, View Article : Google Scholar | |
|
Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H and Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985–988. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Cho H, Kang H, Kim CW, Kim HY, Jang JW, Yoon SK and Lee CD: Phenotypic characteristics of PD-1 and CTLA-4 expression in symptomatic acute hepatitis A. Gut Liver. 10:288–294. 2016. View Article : Google Scholar : | |
|
Radziewicz H, Ibegbu CC, Hon H, Osborn MK, Obideen K, Wehbi M, Freeman GJ, Lennox JL, Workowski KA, Hanson HL and Grakoui A: Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol. 82:9808–9822. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, Alexander G, Finney H, Lawson A, Plunkett FJ, et al: Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 205:2111–2124. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wongjitrat C, Sukwit S, Chuenchitra T, Seangjaruk P, Rojanasang P, Romputtan P and Srisurapanon S: CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection. J Med Assoc Thai. 96(Suppl 1): S54–S59. 2013.PubMed/NCBI | |
|
Kennedy PTF, Sandalova E, Jo J, Gill U, Ushiro-Lumb I, Tan AT, Naik S, Foster GR and Bertoletti A: Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology. 143:637–645. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Velazquez VM and Grakoui A: Immune quiescence and hepatitis B virus: Tolerance has its limits. Gastroenterology. 143:529–532. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Peng G, Luo B, Li J, Zhao D, Wu W, Chen F and Chen Z: Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients. J Clin Immunol. 31:195–204. 2011. View Article : Google Scholar | |
|
Schuette V, Embgenbroich M, Ulas T, Welz M, Schulte- Schrepping J, Draffehn AM, Quast T, Koch K, Nehring M, König J, et al: Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4. Proc Natl Acad Sci USA. 113:10649–10654. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, Micco L, Nebbia G, Kennedy PT, Geretti AM, Dusheiko G and Maini MK: Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology. 53:1494–1503. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YM, Zhang GY, Wang Y, Hu M, Zhou JJ, Sawyer A, Cao Q, Wang Y, Zheng G, Lee VW, et al: Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out mice. Clin Exp Immunol. 188:195–207. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dai K, Huang L, Sun X, Yang L and Gong Z: Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection. J Leukoc Biol. 98:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nitschke K, Luxenburger H, Kiraithe MM, Thimme R and Neumann-Haefelin C: CD8+ T-cell responses in hepatitis B and C: The (HLA-) A, B, and C of hepatitis B and C. Dig Dis. 34:396–409. 2016. View Article : Google Scholar | |
|
Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN and Walsh GM: Effective antigen presentation to helper T cells by human eosinophils. Immunology. 149:413–422. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Sun XH, Zhu XJ, Jin SG, Zeng ZJ, Zhou ZH, Yu Z and Gao YQ: HBcAg induces PD-1 upregulation on CD4+ T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Lab Invest. 92:295–304. 2012. View Article : Google Scholar | |
|
Wang H, Wu D, Wang X, Chen G, Zhang Y, Yan W, Luo X, Han M and Ning Q: Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways. Biol Chem. 397:1173–1185. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Raziorrouh B, Heeg M, Kurktschiev P, Schraut W, Zachoval R, Wendtner C, Wächtler M, Spannagl M, Denk G, Ulsenheimer A, et al: Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules. PLoS One. 9:e1057032014. View Article : Google Scholar | |
|
Walker LS and Sansom DM: The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol. 11:852–863. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Halpert MM, Konduri V, Liang D, Chen Y, Wing JB, Paust S, Levitt JM and Decker WK: Dendritic cell-secreted cytotoxic T-lymphocyte-associated protein-4 regulates the T-cell response by downmodulating bystander surface B7. Stem Cells Dev. 25:774–787. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, et al: Basis of CTLA-4 function in regulatory and conventional CD4+ T cells. Blood. 119:5155–5163. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ville S, Poirier N, Blancho G and Vanhove B: Co-stimulatory blockade of the CD28/CD80-86/CTLA-4 balance in transplantation: Impact on memory T cells? Front Immunol. 6:4112015. View Article : Google Scholar : PubMed/NCBI | |
|
Cloutier JF and Veillette A: Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med. 189:111–121. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Yamane H and Paul WE: Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 28:445–489. 2010. View Article : Google Scholar | |
|
Tang ZS, Hao YH, Zhang EJ, Xu CL, Zhou Y, Zheng X and Yang DL: CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade. Mol Med Rep. 14:1107–1116. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, Vie H, Clémenceau B, Blancho G and Vanhove B: Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells. PLoS One. 8:e831392013. View Article : Google Scholar : | |
|
Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM and Dustin ML: The immunological synapse: A molecular machine controlling T cell activation. Science. 285:221–227. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Alegre ML, Shiels H, Thompson CB and Gajewski TF: Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol. 161:3347–3356. 1998.PubMed/NCBI | |
|
Turner MS, Isse K, Fischer DK, Turnquist HR and Morel PA: Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes. Diabetologia. 57:1428–1436. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Smeets RL, Fleuren WW, He X, Vink PM, Wijnands F, Gorecka M, Klop H, Bauerschmidt S, Garritsen A, Koenen HJ, et al: Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol. 13:122012. View Article : Google Scholar : PubMed/NCBI | |
|
Yin Y, Wu C, Song J, Wang J, Zhang E, Liu H, Yang D, Chen X, Lu M and Xu Y: DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic. PLoS One. 6:e225242011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou C, Peng G, Jin X, Tang J and Chen Z: Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: Implication of its potential use as a therapeutic vaccine. Clin Immunol. 137:190–198. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Fazilleau N, Mark L, McHeyzer-Williams LJ and McHeyzer- Williams MG: Follicular helper T cells: Lineage and location. Immunity. 30:324–335. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA and Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541–547. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CJ, Heuts F, Ovcinnikovs V, Wardzinski L, Bowers C, Schmidt EM, Kogimtzis A, Kenefeck R, Sansom DM and Walker LS: CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement. Proc Natl Acad Sci USA. 112:524–529. 2015. View Article : Google Scholar | |
|
Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, et al: Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4. Science. 332:600–603. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Ma S, Tang L, Li Y, Wang W, Huang X, Lai Q, Zhang M, Sun J, Li CK, et al: Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology. 58:1277–1286. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, Jiang S, Kuchroo VK, Mathis D, Roncarolo MG, et al: Regulatory T cells: Recommendations to simplify the nomenclature. Nat Immunol. 14:307–308. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shevach EM and Thornton AM: tTregs, pTregs, and iTregs: Similarities and differences. Immunol Rev. 259:88–102. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kolar P, Knieke K, Hegel JK, Quandt D, Burmester GR, Hoff H and Brunner-Weinzierl MC: CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 60:123–132. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Guntermann C and Alexander DR: CTLA-4 suppresses proximal TCR signaling in resting human CD4+ T cells by inhibiting ZAP-70 Tyr319 phosphorylation: A potential role for tyrosine phosphatases. J Immunol. 168:4420–4429. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hou TZ, Verma N, Wanders J, Kennedy A, Soskic B, Janman D, Halliday N, Rowshanravan B, Worth A, Qasim W, et al: Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 129:1458–1468. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mellor AL and Munn DH: IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol. 4:762–774. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B and Zhang JZ: Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol. 19:133–140. 2007. View Article : Google Scholar | |
|
Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG and Janssen HL: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 41:771–778. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, et al: Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 177:739–747. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tavakolpour S, Alavian SM and Sali S: Manipulation of regulatory cells' responses to treatments for chronic hepatitis B virus infection. Hepat Mon. 16:e379272016. View Article : Google Scholar : PubMed/NCBI | |
|
Feng IC, Koay LB, Sheu MJ, Kuo HT, Sun CS, Lee C, Chuang WL, Liao SK, Wang SL, Tang LY, et al: HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. J Biomed Sci. 14:43–57. 2007. View Article : Google Scholar | |
|
Chen W, Jin W and Wahl SM: Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4+ T cells. J Exp Med. 188:1849–1857. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Kalathil S, Lugade AA, Miller A, Iyer R and Thanavala Y: Higher frequencies of GARP+CTLA-4+Foxp3+ T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality. Cancer Res. 73:2435–2444. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Cheng LS, Wu SD, Wang SQ, Li L, She WM, Li J, Wang JY and Jiang W: IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection. Clin Sci. 130:907–919. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jeffery HC, Jeffery LE, Lutz P, Corrigan M, Webb GJ, Hirschfield GM, Adams DH and Oo YH: Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 188:394–411. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Walker LS: Treg and CTLA-4: Two intertwining pathways to immune tolerance. J Autoimmun. 45:49–57. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fontenot JD, Gavin MA and Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 4:330–336. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF and Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 27:20–21. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Paterson AM, Lovitch SB, Sage PT, Juneja VR, Lee Y, Trombley JD, Arancibia-Cárcamo CV, Sobel RA, Rudensky AY, Kuchroo VK, et al: Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. J Exp Med. 212:1603–1621. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xia Y and Protzer U: Control of hepatitis B virus by cytokines. Viruses. 9:pii: E182017. View Article : Google Scholar | |
|
Xia Y and Cheng X: Secreted interferon-inducible factors restrict hepatitis B and C virus entry in vitro. J Immunol Res. 2017:48289362017. View Article : Google Scholar : PubMed/NCBI | |
|
Le Vee M, Gripon P, Stieger B and Fardel O: Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos. 36:217–222. 2008. View Article : Google Scholar | |
|
Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, Hösel M, Michler T, Wisskirchen K, Cheng X, Zhang K, et al: Interferon-γ and tumor necrosis Factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis. Gastroenterology. 150:194–205. 2016. View Article : Google Scholar | |
|
Bouezzedine F, Fardel O and Gripon P: Interleukin 6 inhibits HBV entry through NTCP down regulation. Virology. 481:34–42. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P, Knechtle S, Ansari AA, Coppel RL, Liu FT, et al: Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology. 57:708–715. 2013. View Article : Google Scholar : | |
|
Kolar P, Hoff H, Maschmeyer P, Burmester GR and Brunner-Weinzierl MC: CTLA-4 (CD152) blockade does not cause a pro-inflammatory cytokine profile in regulatory T cells. Clin Exp Rheumatol. 29:254–260. 2011.PubMed/NCBI | |
|
Phillips S, Chokshi S, Riva A, Evans A, Williams R and Naoumov NV: CD8+ T cell control of hepatitis B virus replication: Direct comparison between cytolytic and noncytolytic functions. J Immunol. 184:287–295. 2010. View Article : Google Scholar | |
|
Yu Y, Wu H, Tang Z and Zang G: CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients. Cell Mol Immunol. 6:123–127. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Pedicord VA, Montalvo W, Leiner IM and Allison JP: Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance. Proc Natl Acad Sci USA. 108:266–271. 2011. View Article : Google Scholar | |
|
Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, et al: A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol. 59:81–88. 2013. View Article : Google Scholar : PubMed/NCBI |
